Clinical Responses to Gefinitib After Failure of Treatment With Cetuximab in Advanced Non–Small-Cell Lung Cancer

Publisher Website

20 June 2005

journal article
other
Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology

Vol. 23 (18) , 4244-4245
https://doi.org/10.1200/jco.2004.00.5165

Abstract

No abstract available

This publication has 2 references indexed in Scilit:

Dual-Agent Molecular Targeting of the Epidermal Growth Factor Receptor (EGFR)
Cancer Research, 2004
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
JAMA, 2003